Medlab Clinical (Medlab Clinical) Other Long-Term Liabilities : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical Other Long-Term Liabilities?

Medlab Clinical's other long-term liabilities for the quarter that ended in Dec. 2023 was $0.00 Mil.

Medlab Clinical's quarterly other long-term liabilities declined from Dec. 2022 ($0.09 Mil) to Jun. 2023 ($-0.00 Mil) but then increased from Jun. 2023 ($-0.00 Mil) to Dec. 2023 ($0.00 Mil).

Medlab Clinical's annual other long-term liabilities increased from Jun. 2021 ($-0.00 Mil) to Jun. 2022 ($-0.00 Mil) and increased from Jun. 2022 ($-0.00 Mil) to Jun. 2023 ($-0.00 Mil).

Medlab Clinical Other Long-Term Liabilities Historical Data

The historical data trend for Medlab Clinical's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Other Long-Term Liabilities Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial												-	-	-	-	-

Medlab Clinical Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Medlab Clinical Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.